High Content Screening Market, By Product Type (Cell Imaging and Analysis Equipment, Consumables, HCS Software, HCS Services), By Application (Primary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling, Others), By End User (Pharmaceutical Organizations, Biotechnology Organizations, Research Institutes, Independent CRO, Government Organizations, Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2030
High-Content Analysis (HCA) or High-Content Screening (HCS) is a method for obtaining quantitative multi-parametric data from a single cell by combining high-throughput automated imaging with analysis. High-content screening is now established in a much broader area of the life science space as an impartial imaging method to assess cellular function. It was initially developed as a technology to complement conventional biochemical high-throughput screening (HTS) in drug discovery.When compared to high-content screening, high-content imaging (HCI) is typically defined as automated microscopy with a lower throughput (less than 100,000 samples or data points). However, the terms high-content screening and high-content analysis are frequently used interchangeably with high-content imaging.
Market dynamics :
High content screening is on the rise for screening , imaging and identification of molecular entities. For instance, in 2023, Cytiva, a biotechnology and lifesciences company, designed Typhoon laser-scanner platform for versatile imaging and precise quantitation of fluorescent, colorimetric, and radiolabeled nucleic acids and proteins. This was a line of Cytiva’s screening laser products that included Amersham Typhoon IP, Amersham Typhoon IP, Amersham Typhoon 5. Cytiva is Sglobal provider of technologies and services that advances and accelerates the development, manufacture, and delivery of therapeutics.
Key features of the study:
This report provides in-depth analysis of the global high content screening market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global high content screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., GE HealthCare, Olympus Corporation, PerkinElmer Inc., Merck Millipore Corporation, Danaher, Yokogawa Electric Corporation, Sysmex Corporation, and Thorlabs, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global high content screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global high content screening market
Detailed Segmentation:
Global High Content Screening Market, By Product Type:
Cell Imaging and Analysis Equipment
Consumables
HCS Software
HCS Services
Global High Content Screening Market, By Application:
Primary Screening
Target Identification & Validation
Toxicity Studies
Compound Profiling
Others
Global High Content Screening Market, By End User:
Pharmaceutical Organizations
Biotechnology Organizations
Research Institutes
Independent CRO
Government Organizations
Others
Global High Content Screening Market, By Geography:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East:
By Country:
GCC
Israel
Rest of Middle East
Africa
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Becton, Dickinson and Company *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Thermo Fisher Scientific Inc.
GE HealthCare
Olympus Corporation
PerkinElmer Inc.
Merck Millipore Corporation
Danaher
Yokogawa Electric Corporation
Sysmex Corporation
Thorlabs, Inc.
“*” marked represents similar segmentation in other categories in the respective section.